Measuring blood thinner activity in fatty samples
Part of Hormones & metabolism clinical trials.
This trial tests a faster spinning method to measure how well your blood thinner (anti-Xa) is working when your blood sample is fatty. It may help ensure accurate results for patients on certain anticoagulants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be taking a blood thinner that targets anti-Xa, like heparin, enoxaparin, apixaban, or rivaroxaban
- You must have a blood sample already sent to the lab for routine anti-Xa testing
- Your blood sample cannot be very fatty (lipemic) at baseline
- Your blood sample must have enough volume for the test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two types of omega-3s (EPA and DHA) help improve HDL (good cholesterol) and reduce blood clot risk in people with high triglycerides and low HDL cholesterol.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This trial checks if a new method (Cryocheck HexLA Integrated TCA) can accurately find lupus anticoagulant in blood samples. Your leftover blood from regular tests may be used, and it requires no extra visits.
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
Hear when a new Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.